Abstract
The non-steroidal anti-inflammatory drugs still form the mainstay of drug therapy for the rheumatic diseases. They do not cure or permanently reverse the inflammatory process but by reducing pain, swelling and stiffness they can improve function and give considerable symptomatic relief.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, S. A. & Buckler, J. W. (1979). Ibuprofen and flurbiprofen. Clinics Rheum. Dis., 5, 359–379.
Anderson, J. (1977). Disorders of metabolism. In Textbook of Adverse Drug Reactions, ed. Davies, P. M. pp. 217–227. London: Oxford University Press.
Aylward, M., Parker, R. J., Holly, F., Maddock, J. & Davies, D. A. S. (1975). Long term study of indomethacin and alclofenac in treatment of rheumatoid arthritis. Brit. med. J., 2, 7–9.
Baber, N., Halliday, L., Sibeon, R., Littler, T. & Orme, M. L.’ E. (1978). The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study. Clin. Pharmac. Ther., 24, 298–309.
Baber, N., Halliday, L. D. C., Van den Heuvel, W. J. A., Walker, R. W., Sibeon, R., Keenan, J. P., Littler, T. & Orme, M. L.’ E. (1979). Indomethacin in rheumatoid arthritis: Clinical effects, pharmacokinetics and platelet studies in responders and non-responders. Annals Rheum. Dis., 38, 128–137.
Baum, J. J. (1970). Blood salicylate levels and clinical trials with a new form of enteric coated aspirin: Studies in rhematoid arthritis and degenerative joint disease. Clin. Pharmac. Ther., 10, 132–137.
Beeley, L. & Kendall, M. J. (1971). Effect of aspirin on renal clearance of 1,125-diatrizoate. Brit. med. J., 1, 707–708.
Bensen, W. G., Laskin, C. A., Paton, T. W., Little, H. A. & Fam, A. G. (1979). Twice daily dosing of enteric coated aspirin in patients with rheumatic diseases. J. Rheumat., 6, 351–356.
Billings, R. A., Burry, H. C., Emslie, F. S. & Kerr, G. D. (1974). Vasculitis with alclofenac therapy. Brit. med. J., 4, 263–265.
Brogden, R. N., Heel, T. M., Speight, T. M. & Avery, G. S. (1978). Tolmetin: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs, 15, 429–450.
Brogden, R. N., Heel, R. C., Pawes, G. E., Speight, T. M. & Avery, G. S. (1980). Diflunisal: A review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteo-arthrosis. Drugs, 19, 84–106.
Brooks, C. D., Schagel, C. A., Sekhar, N. C. & Sobota, J. T. (1973). Tolerance and pharmacology of ibuprofen. Curr. Ther. Res., 15, 180–190.
Brooks, P. M., Bell, M. A., Lee, P., Rooney, P. J. & Dick, W. C. (1974). The effect of frusemide on indomethacin plasma levels. Brit. J. clin. Pharmac, 1, 485–489.
Brooks, P. M., Bell, M. A., Sturrock, R. D., Famaey, J. P. & Dick, W. C. (1974). The clinical significance of the indomethacin — probenecid interaction. Brit. J. clin. Pharmac., 1, 287–290.
Brooks, P. M. & Buchanan, W. W. (1976). Current management of rheumatoid arthritis. Recent Adv. in Rheumat., 1, 33–87.
Brooks, P. M. & Buchanan, W. W. (1976). Azapropazone — its place in the management of rheumatoid conditions. Curr. Med. Res. Opinion, 4, 94–100.
Brooks, P. M. & Khong, T. K. (1977). Flurbiprofen — aspirin interaction: A double blind cross over study. Curr. Med. Res. Opinion, 5, 53–57.
Brooks, P. M., Roberts, M. S. & Patel, B. (1978). Pharmacokinetics of sustained release aspririn. Brit. J. clin. Pharmac., 5, 337–339.
Brooks, P. M. & Cossum, P. (1978). Salicylates and creatinine clearance re-evaluated. Aust. & N.Z.J. Med., 8, 660–661.
Buchanan, W. W., Rooney, P. J. & Rennie, J. A. N. (1979). Aspirin and salicylates. Clinics Rheum. Dis., 5, 499–539.
Capell, H. A., Rennie, J. A. N., Rooney, P. J., Murdoch, R. M., Hole, D. J., Dick, W. C. & Buchanan, W. W. (1979). Patient compliance: A novel method of testing non-steroidal anti-inflammatory analgesics in rheumatoid arthritis. J. Rheumat., 6, 584–593.
Caruso, I. & Porro, G. B. (1980). Gastroscopic evaluation of anti-inflammatory agents. Brit. med. J., 1, 75–78.
Champion, G. D., Day, R. O., Graham, G. G. & Pauli, P. D. (1975). Salicylates in rheumatoid arthritis. Clinics Rheum. Dis., 1, 245.
Ciccolunghi, S. N., Chaudri, H. A., Schubiger, R. I. & Reddrop, R. (1978). Report on a long term study of up to two years with diclofenac sodium (Voltaren). Scand. J. Rheumat., 22, 86–96.
Day, R. O., Pauli, P. D., Champion, G. D. & Graham, G. G. (1976). Evaluation of an enteric coated aspirin preparation. Aust. & N.Z. J. Med., 6, 45–50.
Dixon, R. L., Henderson, E. S. & Rall, D. P. (1965). Plasma protein binding of methotrexate and its displacement by various drugs. Fed. Proc., 24, 454.
Durao, V., Prata, M. M. & Goncalves, L. M. P. (1977). Modifications of antihypertensive effect of β-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet, 2, 1005–1007.
Ehrlich, G. E. (1979). Tolmetin sodium, meeting the challenge. Clinics Rheum. Dis., 5, 481–497.
Fowler, P. D. (1979). Voltarol: diclofenac sodium. Clinics Rheum. Dis., 5, 427–464.
Furst, D. E., Gupta, N. & Paulus, H. E. (1977). Salicylate metabolism in twins: evidence suggesting a genetic influence and induction of salicylurate formation. J. clin. Invest., 60, 32–42.
Goncalves, L. (1973). Influence of ibuprofen on haemostasis in patients on anticoagulant therapy. J. Int. med. Res., 1, 180–183.
Graham, G. G., Champion, G. D., Day, R. O. & Pauli, P. D. (1977). Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clin. Pharmac. Ther., 22, 410–420.
Grennan, D. M., Ferry, D. G., Ashworth, M. E., Kenny, R. E. & Mackinnon, M. (1979). The aspirin — ibuprofen interaction in rheumatoid arthritis. Brit. J. clin. Pharmac., 8, 497–503.
Hansen, J. M. & Christensen, L. K. (1977). Drug interactions with oral sulphonylurea hypoglycaemic drugs. Drugs, 13, 24–34.
Hoffman, L. M., Krufnick, M. I. & Garcia, H. A. (1972). Interactions of spironolactone and hydrochlorthiazide with aspirin in the rat and dog. J. Pharmac. exp. Ther., 125, 275–282.
Huskisson, E. C., Woolf, D. L., Balme, H. W., Scott, P. J. & Franklyn, S. (1976). Four new antiinflammatory drugs: response and variations. Brit. med. J., 11, 1048–1049.
Huskisson, E. C. (1977). Anti-inflammatory drugs. Semin. Arthritis Rheum., 7, 1–20.
Inman, W. H. (1977). Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Brit. med. J., 1, 1500–1505.
Kimberly, R. P., Bowden, R. E., Keiser, H. R. & Plotz, P. H. (1978). Reduction of renal function by newer non-steroidal anti-inflammatory drugs. Am. J. Med., 64, 804–807.
Koch-Weser, J. & Sellers, E. M. (1971). Drug interactions with coumarin anticoagulants. New Eng. J. Med., 285, 547–558.
Kutt, H. (1975). Interactions of antiepileptic drugs involving multiple mechanisms. In Drug Interactions. ed. Morselli, P. L., pp. 211–222. New York: Raven Press.
Lee, P., Anderson, J. A., Miller, J., Webb, J. & Buchanan, W. W. (1976). An evaluation of the analgesic action and efficacy of anti rheumatic drugs: A study of ten drugs in 684 patients with rheumatoid arthritis. J. Rheumat., 3, 283–294.
Levy, G. & Leonards, J. R. (1971). Urine pH and salicylate therapy. J. Am. med. Ass., 217, 81.
Levy, G., Tsuchiya, T. & Amsel, L. P. (1972). Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin. Pharmac. Ther., 13, 258–268.
Levy, M. (1974). Aspirin use in patients with upper gastrointestinal bleeding and peptic ulcer disease. New Eng. J. Med., 290, 1158–1162.
Macklon, A. F., Craft, A. W., Thompson, M. & Kerr, D. N. S. (1974). Aspirin and analgesic nephropathy. Brit. med. J., 1, 597–600.
Mielens, Z. E., Drobeck, H. P., Rozitis, J., Jr. & San Sone, J. J., Jr. (1968). Interactions of non steroidal anti-inflammatory drugs in rats. J. Pharm. Pharmac, 20, 567–569.
Muller, E. O., Hundt, H. K. L. & Muller, D. G. (1977). Pharmacokinetic and pharmacodynamic implications of long term administration of non-steroidal anti-inflammatory agents. Int. J. clin. Pharmac., 15, 397–402.
New Zealand Rheumatism Study (1974). Aspirin and the kidney. Brit. med. J., 1, 593–600.
Pascale, L. R., Dubin, A., Bronsky, D. & Hoffman, W. S. (1955). Inhibition of the uricosuric action of benemid by salicylate. J. lab. clin. Med., 45, 771–777.
Paulus, H. E., Seigel, M., Mongan, E., Okun, R. & Calabro, J. J. (1971). Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arthritis Rheum., 14, 527–532.
Piper, D. W., Greig, M., Coupland, C. A. E., Hobbin, E. & Shinners, J. (1975). Factors relevant to the prognosis of chronic gastric ulcer. Gut., 16, 714–718.
Prescott, L. F. (1969). Pharmacokinetic drug interactions. Lancet, 2, 1239–1243.
Rhymer, A. R. (1979). Sulindac. Clinics Rheum. Dis., 5, 553–568.
Rhymer, A. R. & Gengos, D. C. (1979). Indomethacin. Clinics Rheum. Dis., 5, 541–552.
Rubin, A., Warrick, P., Wolen, R. L., Chernish, S. M., Ridolfo, A. S. & Gruber, C. M. (1973). Physiological disposition of fenoprofen in man: Metabolism and protein binding of fenoprofen. J. Pharmac. exp. Ther., 183, 447–457.
Rumble, R. H., Brooks, P. M. & Roberts, M. S. (1980). Metabolism of salicylate during chronic aspirin therapy. Brit. J. clin. Pharmac, 9, 41–45.
Runkel, R. A., Chaplin, M., Boost, G., Segre, E. & Forchielli, E. (1972). Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. J. Pharm. Sci., 61, 703–708.
Runkel, R. A., Chaplin, M. D., Sevelius, H., Ortega, E. & Segre, E. (1976). Pharmacokinetics of naproxen overdoses. Clin. Pharmac. Ther., 20, 269–277.
Runkel, R. A., Mroszczak, E., Chaplin, M., Sevelius, H. & Segre, E. J. (1978). Naproxen-probenecid interaction in man. Clin. Pharmac. Ther., 24, 706–713.
Scott, J. T., Denman, A. M. & Dorling, J. (1963). Renal irritation caused by salicylates. Lancet, 1, 344–348.
Segre, E. J. (1979). Naproxen. Clinics Rheum. Dis., 5, 411–426.
Sondervorst, M. (1979). Azapropazone. Clinics Rheum. Dis., 5, 465–480.
Tamisier, J. N. (1979). Ketoprofen. Clinics Rheum. Dis., 5, 381–391.
Tan, S. Y. & Mulrow, P. J. (1977). Inhibition of the renin — aldosterone response to furosemide by indomethacin. J. clin. Endo. Metab., 45, 174–176.
Van Arman, C. G., Nuss, G. W. & Risley, E. A. (1973). Interactions of aspirin, indomethacin and other drugs in adjuvant — induced arthritis in the rat. J. Pharmac. exp. Ther., 187, 400–414.
Van Winzum, C. & Verhaest, L. (1979). Diflunisal. Clinics Rheum. Dis., 5, 707–731.
Verbeeck, R., Tjandramaga, T. B., Mullie, A., Verbesselt, R. & De Schepper, P. J. (1979). The effect of aluminium hydroxide on diflunisal absorption. Brit. J. clin. Pharmac., 7, 519–522.
Wood, P. H. N., Scott, J. T. & St. J. Dixon, A. (1961). Drug induced gastrointestinal bleeding. Lancet, 2, 558.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1980 The contributors
About this chapter
Cite this chapter
Brooks, P.M. (1980). Clinical Effects and Interactions of the Non-Steroidal Anti-Inflammatory Drugs. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_31
Download citation
DOI: https://doi.org/10.1007/978-1-349-05952-2_31
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-05954-6
Online ISBN: 978-1-349-05952-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)